Clinical Trial Update: Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing insulin detemir, insulin aspart, and biphasic insulin aspart 30 added to oral antidiabetic therapy in adults with Type 2 diabetes; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)
• NovoLog (insulin aspart)
• Novolog Mix 30 (biphasic insulin aspart 30 (BIAsp 30))

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2011-07-25